Search - tctmd.com

Displaying 101 - 120 of 345

Sort: Relevancy | Date

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

News Industry News

Very Thin-Strut Biodegradable Polymer Everolimus-Eluting And Sirolimus-Eluting Stents Shown To Be Non-Inferior To Durable Polymer Zotarolimus-Eluting Stents In All-Comers With Coronary Artery Disease

October 30, 2016

News Conference News TCT 2016

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

Todd Neale

October 30, 2016

News Daily News

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Michael O'Riordan

July 05, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2016

Shelley Wood

July 01, 2016

News Daily News

CABG Shows Survival Advantage Over PCI in Nondiabetic Patients With Multivessel Disease

L.A. McKeown

June 29, 2016

News Daily News

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

Michael O'Riordan

June 06, 2016

News Daily News

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

Caitlin E. Cox

May 26, 2016

News Conference News EuroPCR 2016

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

Shelley Wood

May 18, 2016

News Conference News EuroPCR 2016

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Michael O'Riordan

May 17, 2016

News Daily News

Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis

Michael O'Riordan

April 25, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2016

Shelley Wood

March 30, 2016

News Daily News

Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses

Michael O'Riordan

March 30, 2016

News Industry News

Micell Technologies Completes Enrollment in OCT Study Designed to Evaluate Superior Performance of MiStent SES Compared to Xience

March 22, 2016

News Daily News

Un Panel de la FDA Avala por Mayoría Aplastante el Stent Bioabsorbible Absorb

Michael O'Riordan

March 16, 2016

News Daily News

FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent

Michael O'Riordan

March 16, 2016

News Daily News

Better Results With Newer Generation DES in Complex CAD Pave the Way for CABG Comparisons

Todd Neale

March 15, 2016

News Daily News

FDA Review of Absorb Bioresorbable Stent Does Not Tip Hand Ahead of Tomorrow’s Advisory Panel Meeting

Michael O'Riordan

March 14, 2016

News Daily News

Women More Often Than Men Report Lingering Angina After PCI, Raising More Questions

L.A. McKeown

March 06, 2016

News Daily News

Postpone Noncardiac Surgery at Least a Year in Patients with Stents of Any Type: Registry Analysis

L.A. McKeown

March 01, 2016

Advertisement

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Very Thin-Strut Biodegradable Polymer Everolimus-Eluting And Sirolimus-Eluting Stents Shown To Be Non-Inferior To Durable Polymer Zotarolimus-Eluting Stents In All-Comers With Coronary Artery Disease

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

TCTMD’s Top 10 Most Popular Stories for June 2016

CABG Shows Survival Advantage Over PCI in Nondiabetic Patients With Multivessel Disease

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis

TCTMD’s Top 10 Most Popular Stories for March 2016

Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses

Micell Technologies Completes Enrollment in OCT Study Designed to Evaluate Superior Performance of MiStent SES Compared to Xience

Un Panel de la FDA Avala por Mayoría Aplastante el Stent Bioabsorbible Absorb

FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent

Better Results With Newer Generation DES in Complex CAD Pave the Way for CABG Comparisons

FDA Review of Absorb Bioresorbable Stent Does Not Tip Hand Ahead of Tomorrow’s Advisory Panel Meeting

Women More Often Than Men Report Lingering Angina After PCI, Raising More Questions

Postpone Noncardiac Surgery at Least a Year in Patients with Stents of Any Type: Registry Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content